Krpina Kristian, Markić Dean, Rahelić Dražen, Ahel Juraj, Rubinić Nino, Španjol Josip
Department of Urology, Clinical Hospital Center Rijeka, Rijeka.
Arch Ital Urol Androl. 2015 Sep 30;87(3):252-3. doi: 10.4081/aiua.2015.3.252.
Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages combined is 98.8%. Patients diagnosed with metastatic prostate cancer have median survival from 2 to 3 years. We describe a case of 64-year old man who clinically presented with inguinal lymphadenopathy. Because of elevated PSA levels biopsy of prostate was done and adenocarcinoma was diagnosed. Biopsy of inguinal lymph nodes confirmed the diagnosis of prostate cancer. Hormonal treatment was started and at the most recent follow-up, 10 years later, the patient is asymptomatic with no clinical signs of disseminated disease.
前列腺癌是男性中最常见的恶性肿瘤。所有阶段综合起来的5年相对生存率为98.8%。被诊断为转移性前列腺癌的患者中位生存期为2至3年。我们描述了一例64岁男性病例，该患者临床上表现为腹股沟淋巴结病。由于前列腺特异性抗原（PSA）水平升高，进行了前列腺活检，诊断为腺癌。腹股沟淋巴结活检证实了前列腺癌的诊断。开始了激素治疗，在10年后的最近一次随访中，患者无症状，没有播散性疾病的临床迹象。
